[IL-27 regulates the expression of Mac-1, fMLP-R and IL-1beta in human neutrophils through p38 MAPK and PI3K signal

Jian-Ping Li1, Shao-Guang Yang, Chun-Lan Dong

  • 1State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin 300020, China.

Insights

Interleukin-27 (IL-27) modulates human neutrophil responses by regulating Mac-1, fMLP-R, and IL-1beta. These effects are mediated through distinct p38 MAPK and PI3K signaling pathways.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Interleukin-27 (IL-27) is a cytokine with diverse immune regulatory functions.
  • Human neutrophils play a critical role in innate immunity and inflammation.
  • Understanding IL-27's impact on neutrophil function is crucial for inflammatory disease research.

Purpose of the Study:

  • To elucidate the molecular pathways through which IL-27 regulates Mac-1, fMLP-R, and IL-1beta in human neutrophils.
  • To identify the specific signaling cascades involved in IL-27-mediated neutrophil modulation.

Main Methods:

  • Human neutrophils were isolated and stimulated with IL-27.
  • Expression of IL-27 receptor components (WSX-1/TCCR and gp130) was confirmed via RT-PCR.
  • Effects of IL-27 and pathway inhibitors (SB203580, LY294002, U0126) on Mac-1, fMLP-R, and IL-1beta were assessed using RT-PCR, real-time RT-PCR, flow cytometry, and radioimmunoassay.

Main Results:

  • IL-27 receptor components are constitutively expressed in human neutrophils.
  • IL-27 down-regulated Mac-1 expression, an effect dependent on p38 MAPK.
  • IL-27 up-regulated fMLP-R and IL-1beta expression and release, mediated by PI3K signaling.

Conclusions:

  • IL-27 differentially regulates Mac-1, fMLP-R, and IL-1beta in human neutrophils.
  • The p38 MAPK pathway mediates IL-27's effect on Mac-1 expression.
  • The PI3K pathway mediates IL-27's effect on fMLP-R and IL-1beta expression and release.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...